This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs

Event Date: 08/28/2023
Location: Virtual
Subject: FasterCures Silver Linings Scorecard
FDA Participant/Group: N/A
Non FDA Participant/Group: Esther Krofah, Kathryn Forth, Kristin Schneeman (FasterCures);

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

No Significant Event

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

Event Date: 08/29/2023
Location: Silver Spring, MD
Subject: Collaboration and Engagement
FDA Participant/Group: HARINDER CHAHAL; ANNA FERUS; VALERIE HALL; RAVI BHARWANI; JOSHUA SIMMS; MARK RUSSO; AZADA HAFIZ; SEMA HASHEMI; VIDYUT DESAI; DOUGLAS SHAFFER; LIONEL CARTER; HILARY MARSTON; KRISTAN CALLAHAN;
Non FDA Participant/Group: Bongani Ngcobo, Christelna Reynecke, Dimakatso Mathibe, Gontse Moutloatse, Mukona Mphidi, Oitumelo Semete-Makokotlela, Portia Nkambule, Silverani Padayachee, Simphiwe Matsabe, Tohlang Sehloho (South African Health Products Regulatory Authority (SAHPRA));

Official Name: Carol Cave, Acting Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Heidi Rebello, Acting Associate Commissioner for External Affairs

No Significant Event

Official Name: Namandjé N. Bumpus, Ph.D., Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 09/01/2023
Location: Boston, MA
Subject: 8th Annual CAR-TCR Summit; Speaker: Reviewing Regulatory Advice to Guide the Development of the Next Wave of CAR and TCR Therapies
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the 8th Annual CAR-TCR Summit

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 08/30/2023
Location: Virtual
Subject: Rapid Antigen Tests
FDA Participant/Group: TIMOTHY STENZEL;
Non FDA Participant/Group: Janet Handal, Jef Kinney, Laura Burns, Leora Herrmann, Nancy Marlin, Steve Weitzen (Transplant Recipients and Immunocompromised Patient Advocacy Group);

Official Name: Donald Prater, Acting Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine

No Significant Event

Official Name: Tucker Patterson, Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

Event Date: 08/29/2023
Location: Silver Spring, MD
Subject: Rulemaking Concerning Laboratory Developed Tests
FDA Participant/Group: LAUREN ROTH; SIYEON LEE; ELIZABETH HILLEBRENNER; SARA BEARDSLEY; MARCY BUSCH; EITAN BERNSTEIN;
Non FDA Participant/Group: Susan Van Meter (American Clinical Laboratory Association); Amy Leiser, Jerry Masoudi, Kevin King, Scott Danzis (Covington & Burling);